Stock Detail
GENMARK DIAGNOSTICS INC
Sector: IPOs
Latest Quote @ Sat May 5 22:48:09 (15 min delayed)
| N/A |
N/A |
$14.77 |
+0.11 |
0.75% |
|
Last Day's Data
| $14.77 |
$14.84 |
$0.11 |
0.75% |
0.00 |
$14.66 |
| $14.56 |
$14.32 |
40,785.00 |
484.02M |
144,036.00 |
0.00 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 15.16 |
14.96 |
14.64 |
14.44 |
14.12 |
Stock Profile
Osmetech plc engages in the design, development, manufacture, and sale of molecular diagnostics instruments and consumables for DNA, RNA, and protein testing. It offers molecular diagnostics technologies and tools that enable hospitals and laboratories to offer molecular diagnostic services for patient care. The companyÂ's products include eSensor XT-8 System, an eSensor platform that uses electrochemical detection technology to detect nucleic acids on a microarray; eSensor CF Carrier Detection, a cystic fibrosis carrier detection system; and Sensitube that consists of plastic tubes, ergonomically designed sealing caps, and a carousel for use in the Roche LightCycler as a replacement for the Roche glass capillaries. It has operations in the United Kingdom, rest of Europe, the United States, and the Far East. Osmetech plc was founded in 1993 and is based in London, the United Kingdom.
